logo

NGL Fine - Chem Ltd. Financials

15:15 May 30

NGL Fine - Chem Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1138.50
-23.20 (-2.00%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NGL Fine - Chem Ltd. Financials

NGL Fine - Chem Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1138.50
-23.20 (-2.00%)
15:15 May 30
Quality
image/svg+xml

48/100
Medium Financial Strength

Valuation
image/svg+xml

42/100
Mid Valuation

Technical

33/100
Technically Bearish

Strength

4

Weakness

6

Opportunity

0

Threats

0

7.47 %

ROE %

4.87 %

ROA %

33.75

EPS

457.16

BVPS

5.73 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
257.97 317.5 278.08 338.69 368.26
Operating Expenses +
178.23 249.66 243.76 285.42 334.39
Raw Material
100.48 169.67 116.41 170.81 182.41
Increase Decrease in Cost
1.86 -22.68 23.91 -12.13 -0.01
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
28.09 34.85 36.87 45.12 55.55
Miscellaneous Expenses
47.8 67.82 66.57 81.62 96.44
Operating Profit
79.74 67.84 34.32 53.27 33.87
Other Income
8.02 10.68 5.53 14.13 8.63
Depreciation
8.33 10.37 11.29 11.64 12.45
Interest
1.84 1.56 1.2 1.34 2.33
Profit before tax and exceptio..
77.59 66.6 27.36 54.42 27.71
Exceptional Items
0 0 0 0 0
PBT
77.59 66.6 27.36 54.42 27.71
Provision for Taxation
20.87 16.7 6.87 13.1 6.59
Net Profit
56.72 49.9 20.5 41.32 21.12
NET Profit after MI
56.72 49.9 20.5 41.32 21.12
EPS
91.81 80.77 33.18 66.88 34.19
Operating Profit Margin (%)
30.91 21.37 12.34 15.73 9.2
Net Profit Margin (%)
21.99 15.72 7.37 12.2 5.74

NGL Fine - Chem Ltd. Shareholding

Promoter

FII

Public

Mutual Funds

Other Institutions

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 72.70 72.70 72.70 72.70 72.70
FII 0.00 0.00 0.00 0.00 0.10
MF 0.00 0.00 0.00 0.00 0.00
Public 27.30 27.20 27.20 27.20 27.20
Others 0.00 0.10 0.10 0.10 0.00
Others 0.00 0.00 0.00 0.00 0.00
Shareholder Shares Holding %
Research 360 logo
Download Our App On: